Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect.
This report contains market size and forecasts of Large Molecule Injectable Drugs in Global, including the following market information:
Global Large Molecule Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Large Molecule Injectable Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Large Molecule Injectable Drugs include Biogen, AstraZeneca, Roche, Sun Pharmaceutical, Medtronic, Novartis, ​​Baxter, Amgen and Pfizer and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Large Molecule Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Large Molecule Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, by Type, 2021 (%)
Intravenous Injection
Muscle Injection
Subcutaneous Injection
Global Large Molecule Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Large Molecule Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Large Molecule Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Large Molecule Injectable Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Large Molecule Injectable Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
AstraZeneca
Roche
Sun Pharmaceutical
Medtronic
Novartis
​​Baxter
Amgen
Pfizer
Johnson & Johnson